Core Insights - ASP Isotopes Inc. has entered into a contract with a U.S.-based SMR company for preliminary engineering design and planning of an enrichment facility for nuclear fuels, with potential payments totaling up to $2.0 million [1][2] Company Overview - ASP Isotopes Inc. is a pre-commercial stage advanced materials company focused on developing technology and processes for isotope production across multiple industries, employing proprietary Aerodynamic Separation Process technology [4] - The company aims to produce highly enriched isotopes for healthcare and technology sectors, as well as for the nuclear energy sector using Quantum Enrichment technology [4] Industry Context - The demand for advanced nuclear fuels is expected to increase significantly over the next fifty years, with a focus on HALEU and Lithium-6 for future SMRs and nuclear fusion applications [2] - Global energy consumption is projected to double in the next 30 years, necessitating a zero increase in carbon emissions to meet 2050 climate goals [2] - There is a growing demand for various isotopes, including Silicon-28 for quantum computing and Molybdenum isotopes for healthcare applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy [5]

WASHINGTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or "ASPI" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today that its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE"), has entered into a purchase agreement with investors for the issuance of QLE's convertible notes (the "QLE Notes"). The offering of QLE Notes was oversubscri ...

WASHINGTON, Feb. 18, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or "ASPI" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today its intention to commence an offering by its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE"), of up to US$20 million aggregate principal amount of QLE's convertible notes (the "Notes"), subject to market and other c ...

- ASP Isotopes plans to spin a portion of Quantum Leap Energy's common equity to ASP Isotopes' stockholders as of a future record date, in a tax efficient manner. - ASP Isotopes licenses rights to technology related to the enrichment of nuclear fuels to Quantum Leap Energy. ASPI to receive a 10% perpetual royalty on all revenues of Quantum Leap Energy. - ASPI and QLE continue to work with potential customers to help resolve the current nuclear fuel supply chain issues. At current prices, ASPI and QLE has cu ...

Core Viewpoint - ASP Isotopes Inc. is advancing its operations in isotope production, particularly focusing on highly enriched Carbon-14 and Ytterbium-176, with expectations of generating revenue in the near term and expanding its production capabilities through new facilities [1][2][3]. Group 1: Carbon-14 Production - The company and its North American partner, RC14, began processing feedstock for highly enriched Carbon-14 in December 2023, with first revenues expected in the first half of 2024 [1][2]. - A multi-year take-or-pay contract with RC14 guarantees a minimum revenue of $2.5 million per annum, with the first batch processing expected to take approximately six months [2]. Group 2: Ytterbium-176 Facility - Construction of the third isotope enrichment facility in South Africa has commenced, aimed at producing kilogram quantities of highly enriched Ytterbium-176, which is crucial for the production of Lutetium-177 used in oncology [3]. - The facility is expected to start commercial production in 2025, addressing supply chain challenges in the market for Lutetium-177 [3]. Group 3: Quantum Enrichment Technology - The new Ytterbium-176 facility will utilize Quantum Enrichment, an advanced technique under development that employs lasers for isotope production [4]. - The company has entered into MOUs with two US-based Small Modular Reactor companies to utilize Quantum Enrichment for producing HALEU [4]. Group 4: Market Demand and Applications - There is a growing demand for various isotopes, including Silicon-28 for quantum computing and Ytterbium-176 for healthcare applications, indicating a robust market potential for the company's products [6].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ____________________ FORM 10-Q ____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to __________________ Commission File Number: 001-41555 ASP Isotopes Inc. (Exact Name of Regist ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ____________________ Delaware 87-2618235 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1101 Pennsylvania Avenue NW, Suite 300 Washington, DC 20004 (Address of principal executive offices) (Zip Code) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share ASPI Nasdaq Stock Market LLC (Nasdaq Capital Market) Large accelerate ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ____________________ FORM 10-Q ____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to __________________ Commission File Number: 001-41555 ____________________ | --- | --- | |------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Name of exchange Title of each class Trading Symbol on which registered: Common stock, par value $0.01 per share ASPI The Nasdaq Capital Market LLC Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated Filer ☒ Smaller reporting company ☒ Emerging growth company ☒ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO ...